Navegar por autor "Lazaro Quintela, Martín"

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study

2013- Afonso Afonso, Francisco Javier; Lazaro Quintela, Martín; Vázquez Estévez, Sergio; Campos Balea, Begoña; Barón Duarte, Francisco Javier; [et al.]

A Spanish Initiative to Know the Unmet Needs of Women with Lung Cancer:

2019- Campelo, R. G.; Vázquez Rivera, Francisca; Firvida Perez, Jose Luis; Lazaro Quintela, Martín; Vazquez, S.; [et al.]

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study

2019- Conde, E.; Hernandez, S.; Martinez, R.; Angulo, B.; De Castro, J.; [et al.]

Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study

2013- Firvida Perez, Jose Luis; Lazaro Quintela, Martín; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; [et al.]

Biweekly docetaxelcisplatin in chemo-naive patients with advanced squamous carcinoma of the lung: A galician lung cancer group phase II study

2011- Lazaro Quintela, Martín; Areses Manrique, María Carmen; Vázquez Estévez, Sergio; Campos Balea, Begoña; Senin Estor, Clara; [et al.]

Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

2013- Afonso Afonso, Francisco Javier; Antón Aparicio, Luis Miguel; Anido Herranz, Urbano; Fernández Calvo, Ovidio; León Mateos, Luis Ángel; [et al.]

Cost analysis of the management of brain metastases in patients with advanced ALK+ NSCLC: alectinib versus crizotinib

2020- Isla, D.; Massuti, B.; Lazaro Quintela, Martín; de Alda, L. R.; Gordo, R.; [et al.]

Cross-sectional observational study assessing the impact in daily clinical practice of the implementation of cooperative group (SOGUG) guidelines about management of targeted therapies in metastatic renal cell carcinoma (mRCC)(proTECT 2 Study)

2013- León Mateos, Luis Ángel; Lazaro Quintela, Martín; Vázquez Estévez, Sergio

Docetaxel (D) and cisplatin (C) induction chemotherapy followed by biweekly D and C with concurrent thoracic radiotherapy for stage iii nonsmall cell lung cancer (NSCLC). A galician lung cancer group study.

2011- Lazaro Quintela, Martín; Vázquez Estévez, Sergio; Varela Ferreiro, Silvia; Campos Balea, Begoña; Casal Rubio, Joaquín [et al.]

Enzalutamide: a new prostate cancer targeted therapy against the androgen receptor

2015- Afonso Afonso, Francisco Javier; Antón Aparicio, Luis Miguel; Anido Herranz, Urbano; Fernández Calvo, Ovidio; Lazaro Quintela, Martín; [et al.]

EPI.14-15 Real World Clinical Experience of the Galician Lung Cancer Group: Afatinib in Patients with EGFR Positive Mutation

2019- AGRASO BUSTO, SARA; VARELA POSE, VANESA; Fernández Nuñez, Natalia; Firvida Perez, Jose Luis; Santome, L.; [et al.]

Erlotinib as second-line therapy for patients with advanced non-small-cell lung cancer and wild-type EGFR tumors

2015- Lazaro Quintela, Martín; Areses Manrique, María Carmen; Huidobro Vence, Gerardo; Villanueva Silva, María José; Casal Rubio, Joaquín [et al.]

Evaluation of clinical use and effectiveness of darbepoetin alfa in cancer patients with chemotherapy-induced anemia

2012- Lazaro Quintela, Martín; Martin De Segovia, Jose Maria Joaquin

First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients

2012- Firvida Perez, Jose Luis; León Mateos, Luis Ángel; Lazaro Quintela, Martín; Vázquez Estévez, Sergio

Full-dose Cisplatin and Oral Vinorelbine Concomitant with Radiotherapy in Unresectable Stage III Non-small Cell Lung Cancer: A Multi-center Phase II Study

2014- Firvida Perez, Jose Luis; Lazaro Quintela, Martín; Casal Rubio, Joaquín

Hiperfracctioned Radiochemotherapy in Small Cell Lung Cancer, a Monoinstutional Experience

2015- Lazaro Quintela, Martín; Gómez Caamaño, Antonio; Calvo Crespo, Patricia; Taboada Valladares, Maria Begoña

Induction chemotherapy with docetaxel (D) and cisplatin (C) followed by concurrent thoracic radiotherapy with biweekly d and C for stage III non-small cell lung cancer (NSCLC) - A galician lung cancer group study

2011- Anido Herranz, Urbano; Firvida Perez, Jose Luis; Lazaro Quintela, Martín; Calvo Crespo, Patricia; Vázquez Estévez, Sergio; [et al.]

Long-term progression-free survival (PFS) in patients under sunitinib treatment: A SOG-GU experience

2012- Afonso Afonso, Francisco Javier; Antón Aparicio, Luis Miguel; Anido Herranz, Urbano; Fernández Calvo, Ovidio; León Mateos, Luis Ángel; [et al.]

Metastatic castration-resistant prostate cancer: changing landscape with cabazitaxel

2014- Antón Aparicio, Luis Miguel; Fernández Calvo, Ovidio; León Mateos, Luis Ángel; Lazaro Quintela, Martín; Vázquez Estévez, Sergio; [et al.]

PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis

2020- García González, Jorge José; RUIZ BAÑOBRE, JUAN; Afonso Afonso, Francisco Javier; Amenedo-Gancedo, Margarita; Areses Manrique, María Carmen; [et al.]

Repositorio digital RUNA

Navegar por autor "Lazaro Quintela, Martín"

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study ﻿

A Spanish Initiative to Know the Unmet Needs of Women with Lung Cancer: ﻿

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study ﻿

Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study ﻿

Biweekly docetaxelcisplatin in chemo-naive patients with advanced squamous carcinoma of the lung: A galician lung cancer group phase II study ﻿

Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor ﻿

Cost analysis of the management of brain metastases in patients with advanced ALK+ NSCLC: alectinib versus crizotinib ﻿

Cross-sectional observational study assessing the impact in daily clinical practice of the implementation of cooperative group (SOGUG) guidelines about management of targeted therapies in metastatic renal cell carcinoma (mRCC)(proTECT 2 Study) ﻿

Docetaxel (D) and cisplatin (C) induction chemotherapy followed by biweekly D and C with concurrent thoracic radiotherapy for stage iii nonsmall cell lung cancer (NSCLC). A galician lung cancer group study. ﻿

Enzalutamide: a new prostate cancer targeted therapy against the androgen receptor ﻿

EPI.14-15 Real World Clinical Experience of the Galician Lung Cancer Group: Afatinib in Patients with EGFR Positive Mutation ﻿

Erlotinib as second-line therapy for patients with advanced non-small-cell lung cancer and wild-type EGFR tumors ﻿

Evaluation of clinical use and effectiveness of darbepoetin alfa in cancer patients with chemotherapy-induced anemia ﻿

First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients ﻿

Full-dose Cisplatin and Oral Vinorelbine Concomitant with Radiotherapy in Unresectable Stage III Non-small Cell Lung Cancer: A Multi-center Phase II Study ﻿

Hiperfracctioned Radiochemotherapy in Small Cell Lung Cancer, a Monoinstutional Experience ﻿

Induction chemotherapy with docetaxel (D) and cisplatin (C) followed by concurrent thoracic radiotherapy with biweekly d and C for stage III non-small cell lung cancer (NSCLC) - A galician lung cancer group study ﻿

Long-term progression-free survival (PFS) in patients under sunitinib treatment: A SOG-GU experience ﻿

Metastatic castration-resistant prostate cancer: changing landscape with cabazitaxel ﻿

PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis ﻿

A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study

A Spanish Initiative to Know the Unmet Needs of Women with Lung Cancer:

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Patients with Non–Small Cell Lung Carcinoma: the ROSING Study

Bevacizumab (B) (10 mg/kg) in combination with cisplatin (C) and docetaxel (D) administered every 2 weeks in patients (p) with advanced non-squamous non-Small Cell Lung Cancer (nsNSCLC): GGCP047/10 study

Biweekly docetaxelcisplatin in chemo-naive patients with advanced squamous carcinoma of the lung: A galician lung cancer group phase II study

Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor

Cost analysis of the management of brain metastases in patients with advanced ALK+ NSCLC: alectinib versus crizotinib

Cross-sectional observational study assessing the impact in daily clinical practice of the implementation of cooperative group (SOGUG) guidelines about management of targeted therapies in metastatic renal cell carcinoma (mRCC)(proTECT 2 Study)

Docetaxel (D) and cisplatin (C) induction chemotherapy followed by biweekly D and C with concurrent thoracic radiotherapy for stage iii nonsmall cell lung cancer (NSCLC). A galician lung cancer group study.

Enzalutamide: a new prostate cancer targeted therapy against the androgen receptor

EPI.14-15 Real World Clinical Experience of the Galician Lung Cancer Group: Afatinib in Patients with EGFR Positive Mutation

Erlotinib as second-line therapy for patients with advanced non-small-cell lung cancer and wild-type EGFR tumors

Evaluation of clinical use and effectiveness of darbepoetin alfa in cancer patients with chemotherapy-induced anemia

First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients

Full-dose Cisplatin and Oral Vinorelbine Concomitant with Radiotherapy in Unresectable Stage III Non-small Cell Lung Cancer: A Multi-center Phase II Study

Hiperfracctioned Radiochemotherapy in Small Cell Lung Cancer, a Monoinstutional Experience

Induction chemotherapy with docetaxel (D) and cisplatin (C) followed by concurrent thoracic radiotherapy with biweekly d and C for stage III non-small cell lung cancer (NSCLC) - A galician lung cancer group study

Long-term progression-free survival (PFS) in patients under sunitinib treatment: A SOG-GU experience

Metastatic castration-resistant prostate cancer: changing landscape with cabazitaxel

PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis